Navigation Links


Berman in Medical News

Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million

BOSTON, Aug. 5 /PRNewswire/ --- Attorneys representing consumers and third-party payors today announced a proposed $41.5 million settlement with drug manufacturers Merck & Co. (NYSE: MRK ) and Schering-Plough Corporation (NYSE: SGP ) to settle allegations the companies suppr...

Hagens Berman Sobol Shapiro: McKesson Settles RICO Lawsuit for $350 Million

SEATTLE, Nov. 21 /PRNewswire/ -- Attorneys representing consumers and third-party payers today announced a proposed landmark $350 million settlement with healthcare services giant McKesson (NYSE: MCK ) to settle allegations the company fraudulently inflated the price of more than 400 prescriptio...

Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign

SEATTLE, Nov. 19 /PRNewswire/ -- A group of consumers filed a proposed nationwide class-action lawsuit earlier this week against Bayer Healthcare LLC, a subsidiary of Bayer AG (FRA: BAY), alleging the pharmaceutical giant skirted FDA requirements in marketing two aspirin-based drugs. (Logo...

Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics

Spectranetics Replaces President and CEO John G. Schulte with Chairman Emile J. Geisenheimer. SEATTLE, Oct. 29 /PRNewswire/ -- Hagens Berman Sobol Shapiro filed a class-action lawsuit on behalf of those who purchased Spectranetics Company stock (Nasdaq: SPNC ), claimi...

Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation

SEATTLE, Aug. 29 /PRNewswire/ -- Attorneys representing consumers in a case accusing McKesson (NYSE: MCK ) of illegally rigging the price of virtually every prescription drug have crossed the final procedural hurdles and are now preparing for a trial set for December 1 in U.S. District Court ...

Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck

Lawsuit claims manufacturers misled consumers about the use of Zetia and Vytorin. SEATTLE, June 10 /PRNewswire/ -- Last week the U.S. District Court in New Jersey appointed Hagens Berman, along with four other firms, co-counsel in a case against Schering-Plough (...

Hagens Berman Sobol Shapiro: Nationwide Class Action Certified in Average Wholesale Price Litigation

Industry giant, McKesson, facing billions of dollars in damages. BOSTON, March 24 /PRNewswire/ -- Last week a United States District Court judge certified a nationwide class-action lawsuit against McKesson Corporation (NYSE: MCK ) that could become the largest class action in the United S...

CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough

Lawsuit claims companies knowingly misled consumers on the use of Zetia and Vytorin. NEWARK, N.J., Jan. 24 /PRNewswire/ -- Hagens Berman Sobol Shapiro filed a proposed class-action lawsuit against Merck (NYSE: MRK ) and Schering-Plough (NYSE: SGP ), manufacturers...

Hagens Berman Sobol Shapiro Announces Investigation Into Marketing of Vytorin and Zetia

SEATTLE, Jan. 16 /PRNewswire/ -- Hagens Berman Sobol Shapiro has begun an investigation concerning actions by Merck (NYSE: MRK ) and Schering-Plough (NYSE: SGP ), manufacturers of Zetia and Vytorin. The investigation is looking into charges of whether Merck and Schering-Plough violated state...

Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case

Court action could set path for future, national litigation. BOSTON, Nov. 2 /PRNewswire/ -- Today a U.S. District Court Judge awarded consumers millions of dollars in damages against drug giants AstraZeneca (NYSE: AZN ) and Bristol-Myers Squib (NYSE: BMY ) for the companies' role in un...
Berman in Medical Technology

Lutonix Inc. Announces $20 Million Series B Financing

... Venture Partners; Jay Schmelter, Managing Director of RiverVest Venture Partners; Mike Berman, past medical device company executive and President of berman Medical; co-founder and Chief Technical Officer, Lixiao Wang PhD; and co-founder, President, and CEO, Dennis Wahr, M.D. "This substantial funding fr...

Allegheny General Hospital Performs First Liver Transplant

...hairman of AGH's Department of Surgery. Christine berman was admitted to AGH on October 28 suffering from a... and a week in AGH's surgical intensive care unit, berman 's new liver is functioning perfectly well, Dr. Ca...iarelli said. The mother of three young children, berman said she and her family are most grateful for the ...

Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants

...tion to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise. References (1) berman RM, Marcus RN, Swanink R, Carson Jr WH, McQuade RD, Khan A. Efficacy and safety of aripiprazole as adjunctive therapy in major depre...
Berman in Medical Dictionary

Subungual

...s subungual exostectomy? Post a question - any question - to the ... Subungual exostosis. Subungual hematoma. Lichen planus of ... Dr. Kevin berman discusses amelanotic melanoma and subungual melanoma. ... Treatment of subungual melanoma is primarily surgical, with complete excision being ...

Relationships

...reat relationships with advice from our experts. ... Relationships . Couples. Dating. Sex. Parenting. Family. Friends. Abuse. Lisa Kogan. Dr. Laura berman ... The place for everything in Oprah's world. Get health, beauty, recipes, money, decorating and relationship advice to live your best life on ...
Berman in Biological News

Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial

"The report today that the FDA has approved the first human clinical trial of an embryonic stem cell-based intervention raises important ethical considerations, but not only, or even primarily, because what is at issue is an embryonic stem cell-based intervention. Although deep-seated disagreemen...

San Diego Supercomputer Center and UCSD announce 'Triton Resource'

...m -- named after the mythical sea god and his three-pronged trident, whose image was adopted by UC San Diego as its mascot in 1964 -- was announced by berman as part of the dedication ceremonies for the supercomputer center's 80,000 square-foot building addition, which will double the size of the existing f...

Rethinking who should be considered 'essential' during a pandemic flu outbreak

...ublished in the journal of Biosecurity and Bioterrorism . The report, led by Nancy Kass, Sc.D, Deputy Director of Public Health for the Johns Hopkins berman Institute of Bioethics, provides ethical guidance for pandemic planning that ensures a skeletal infrastructure remain intact at all times. Dr. Kass sa...

Brain's reward circuit activity ebbs and flows with a woman's hormonal cycle

...owever, how these hormones influence reward circuit activity in humans has remained unclear. To pinpoint hormone effects on the reward circuit, berman and colleagues scanned the brain activity of 13 women and 13 men while they performed a task involving simulated slot machines. The women were scanned...

Brain Scans Reveal How Gene May Boost Schizophrenia Risk

... a mere difference in degree ?in dopamine activity in these two brain areas," explained NIMH's Dr. Andreas Meyer-Lindenberg, who, along with Dr. Karen berman and colleagues, reported their findings in the April 10, 2005 online edition of Nature Neuroscience. The NIMH study also for the first time confirm...
Berman in Biological Technology

Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation

Hagens Berman suit claims company insiders knowingly misrepresented the company to investors SEATTLE, Jan. 18 /PRNewswire/ -- Hagens Berman Sobol Shapiro filed a proposed class-action lawsuit on behalf of CellCyte Genetics Corporation (OTC Bulletin Board: CCYG) shareho...

Hagens Berman Sobol Shapiro Announces Proposed Class-Action Lawsuit Against CellCyte

SEATTLE, Jan. 14 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP ( http://www.hbsslaw.com/ccyg.htm ) today announced it filed a proposed class-action lawsuit in the United States District Court for the Western District of Washington at Seattle on behalf of purchasers of the common stock of Cel...

Hagens Berman Sobol Shapiro Investigating CellCyte

SEATTLE, Jan 9 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP ( http://www.hbsslaw.com/cellcyte.htm ) today announced it is investigating the business practices of CellCyte (OTC Bulletin Board: CCYG) for potential violations of securities laws. The investigation comes after CellCyte's share...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

...ical activity in patients (pts) with advanced melanoma treated with ipilimumab" (Abstract #3020, Developmental Therapeutics: Immunotherapy Session) D. berman - Poster discussion from 2:00 p.m. to 6:00 p.m. local time on Sunday, May 31, 2009. "Phase 2 trial of extended dose an...

InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008

...uch expressions. For further information, visit the company's Web Site: http://www.instacare.net . Company Contact: InstaCare Corp. Keith berman (805) 446-1973 info@instacare.net InstaCare Corp. Condensed Consolidated Balance Sheets ...

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)

...y of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA. June 18 2003;289(23):3095-3105. (3) berman RM, Marcus RN, Swanink R, et al. The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Multicenter, ...

John Bergman, co-founder of Guild Software

...edition when he and his father were chased out of the water by a 10-foot bull shark. "You inevitably get some blood in the water when you spear fish," berman mused. As a result of the time he spent on a sailboat, or completely submerged in the peaceful blue waters of the Caribbean, Bergman, now 28, devel...
Other TagsGripsMexiClaiClaiClaiClaifathe
(Date:11/28/2009)...CHICAGO, Nov. 28 Get ready for ...n the clinical routine when Siemens introduces...bly and Annual Meeting of the Radiological Society...ber 3 at McCormick Place (Booth #825, East Buildin...go. via , Siemens, new imaging software for m...
(Date:11/28/2009)...ne variation believed to affect circadian rhythm,...) -- New research suggests that an internal body c...he development of bipolar disorder in children. ,...e genetic makeup of 152 children with bipolar diso...ood swings, and 140 children without the disorder....
(Date:11/27/2009)...EDFORD, Mass., Nov. 27 G... a supplier of precision technology products and s...al meeting of the Company,s shareholders has been ...d location of the meeting will be announced in due...eived a requisition notice from Stephen Bershad, a...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issu...us genomic data. It shows that the lethality of t...5) during the virus,s current outbreak in the spri...k of 2.0 (s.d. 0.1). The H1N1 infectivity count, h... Boston (PRWEB) November 27, 2009 -- Biotech fi...
(Date:11/27/2009)... FRANCISCO, Nov. 27 The ...at Blair Lambert, CFO/COO, will present at the NAS...at the May Fair Hotel in London, England, on Wedne...o listen to a live broadcast of The Gymboree Corpo...g on to www.gymboree.com, click on "Our Company" a...
Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
(Date:11/26/2009)...sistant Staphylococcus Aureus ) and other drug-re...mperature plasma prototype devices have been devel...ericidal cocktails. , Two prototype devices have... healthy skin (e.g. hands and feet) in hospitals a...threat; and another to shoot bacteria-killing agen...
(Date:11/25/2009)... Head of the Cell Death Research Laboratory in the...been awarded the prestigious Johnson & Johnson Foc...cause of brain cell damage in Parkinson,s disease....ts in support of innovation and excellence in scie...ed earlier this month at an event at the Hyatt Reg...
(Date:11/24/2009)...rs it has been prescribed by traditional healers i...es and stomach pain to fever and flu. , Now for t... have been able to scientifically prove the pain r... known as Brazilian mint. , Testing this ancient ...rcher Graciela Rocha was able to show that when pr...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2NxStage Patient Takes Dialysis Machine on Third Annual Patient Good Will Tour 57690 1NxStage Patient Takes Dialysis Machine on Third Annual Patient Good Will Tour 57690 2NxStage Patient Takes Dialysis Machine on Third Annual Patient Good Will Tour 57690 3PDL BioPharma Announces Conversion Rate Adjustment for Its 2 00 25 Convertible Senior Notes Due February 15 2012 14151 1PDL BioPharma Announces Conversion Rate Adjustment for Its 2 00 25 Convertible Senior Notes Due February 15 2012 14151 2Gateway Responding To Increased Need for Treatment Among Middle Income Substance Abusers 57682 1Gateway Responding To Increased Need for Treatment Among Middle Income Substance Abusers 57682 2
Other Contentsveinveinveinveinveinveinveinveinarteryarteryarteryarteryarteryarteryarteryarterypurepurepurepurepurepurepurepurepurepulmonarypulmonarypulmonarypulmonarypulmonarypulmonarypulmonarypyloricpyloricpyruvicpyruviclocilocilociloci